Clinical Trials Feel the Coronavirus Crunch

In this ISSUE

Three Key Takeaways from SCOPE

The Importance of Site Selection

Clinical Data Manager: A Roadmap for the Future

Coronavirus

Measuring the Impact of the COVID-19 Outbreak on Clinical Trials

The impact of the COVID-19 pandemic has raised several critical questions about the short- and medium-term implications for trial sites and sponsors.
... /Read more/

Use of RWE in Clinical Development to Enhance Regulatory Submission
Tuesday, April 7, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Register now

Regulatory Affairs

FDA Updates Clinical Research Policy to Reflect COVID-19 Disruptions

FDA is offering advice and added flexibility to help sponsors adjust ongoing and planned clinical research programs during the COVID-19 outbreak.
... /Read more/

Outsourcing to CROs: Expediting Clinical Operations or Oversight Nightmare?
Tuesday, April 28, 2020 1pm EDT | 12pm CDT | 10am PDT
Register now

Blog

Clinical Trials Feel the Coronavirus Crunch

With the Coronavirus causing significant disruptions in the clinical trials industry, Sponsors should expect data quality issues due to missed visits and a reduction in enrollment rates.
... /Read more/

Digital Health

Investing in Data Science to Unlock Clinical Data Value

The need for biopharma companies to equip data managers with the training and resources necessary to capitalize on new digital health tools.
... /Read more/

Industry News

Latest in People and Business News

The latest happenings in the industry from the past month, all in one place.
... /Read more/

Calendar

/ 9th Annual Publication and Clinical Trial Transparency — 6/2-6/3 /

/ DIA 2020 Global Annual Meeting — 6/14-6/18 /

/ Rare Disease Innovation and Partnering Summit — 6/24-6/26 /

Ask the editor

Lisa Henderson
Editor in Chief
LHenderson@mmhgroup.com

Advertise

Todd Baker
Group Publisher
tbaker@mmhgroup.com

website / blog / advertise / subscribe